Integrated BioPharma, Inc. announced earnings results for the fourth quarter ended June 30, 2021. For the fourth quarter, the company announced sales was USD 17.058 million compared to USD 13.535 million a year ago. Operating income was USD 1.312 million compared to USD 618,000 a year ago. Net income was USD 4.507 million compared to USD 1.901 million a year ago. Basic earnings per share from continuing operations was USD 0.15 compared to USD 0.06 a year ago. Diluted earnings per share from continuing operations was USD 0.14 compared to USD 0.06 a year ago. For the full year, sales was USD 63.559 million compared to USD 52.769 million a year ago. Operating income was USD 5.784 million compared to USD 3.259 million a year ago. Net income was USD 8.013 million compared to USD 4.108 million a year ago. Basic earnings per share from continuing operations was USD 0.27 compared to USD 0.14 a year ago. Diluted earnings per share from continuing operations was USD 0.25 compared to USD 0.13 a year ago.